Related references
Note: Only part of the references are listed.Long-term results and GvHD after prophylactic and preemptive donor lymphocyte infusion after allogeneic stem cell transplantation for acute leukemia
Christoph Schmid et al.
BONE MARROW TRANSPLANTATION (2022)
Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis
Aidan M. Kirkham et al.
LEUKEMIA & LYMPHOMA (2022)
Relapse of acute myeloid leukemia after allogeneic hematopoietic cell transplantation: clinical features and outcomes
Masamitsu Yanada et al.
BONE MARROW TRANSPLANTATION (2021)
Defining the Role of Donor Lymphocyte Infusion in High-Risk Hematologic Malignancies
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Granulocyte Colony-Stimulating Factor Effectively Mobilizes TCR γδ and NK Cells Providing an Allograft Potentially Enhanced for the Graft-Versus-Leukemia Effect for Allogeneic Stem Cell Transplantation
Lia Minculescu et al.
FRONTIERS IN IMMUNOLOGY (2021)
A Retrospective Comparison of DLI and gDLI for Post-Transplant Treatment
Sylvain Lamure et al.
JOURNAL OF CLINICAL MEDICINE (2020)
G-CSF administration prior to donor lymphocyte apheresis promotes anti-leukaemic effects in allogeneic HCT patients
Corina Schneidawind et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Single-center experience suggests donor lymphocyte infusion may promote long-term survival in children with high-risk acute lymphoblastic leukemia
Nicole Liberio et al.
PEDIATRIC BLOOD & CANCER (2019)
Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT
Christoph Schmid et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Classification systems for chronic graft-versus-host disease
Stephanie J. Lee
BLOOD (2017)
Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience
A. M. Willasch et al.
BONE MARROW TRANSPLANTATION (2017)
Safety of pre-emptive donor lymphocyte infusions (DLI) based on mixed chimerism (MC) in peripheral blood or bone marrow subsets in children undergoing hematopoietic stem cell transplant (HSCT) for hematologic malignancies
A. Liou et al.
BONE MARROW TRANSPLANTATION (2017)
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT
P. Tsirigotis et al.
BONE MARROW TRANSPLANTATION (2016)
Chimerism-Based Pre-Emptive Immunotherapy with Fast Withdrawal of Immunosuppression and Donor Lymphocyte Infusions after Allogeneic Stem Cell Transplantation for Pediatric Hematologic Malignancies
Biljana Horn et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2015)
Mobilized peripheral blood grafts include more than hematopoietic stem cells: the immunological perspective
F. Saraceni et al.
BONE MARROW TRANSPLANTATION (2015)
Adoptive therapy with donor lymphocyte infusion after allogenic hematopoietic SCT in pediatric patients
J. Gozdzik et al.
BONE MARROW TRANSPLANTATION (2015)
Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose
Merav Bar et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2013)
G-CSF mobilized vs conventional donor lymphocytes for therapy of relapse or incomplete engraftment after allogeneic hematopoietic transplantation
K. K. S. Abbi et al.
BONE MARROW TRANSPLANTATION (2013)
Outcomes of Immunological Interventions for Mixed Chimerism Following Allogeneic Stem Cell Transplantation in Children With Juvenile Myelomonocytic Leukemia
Jiro Inagaki et al.
PEDIATRIC BLOOD & CANCER (2013)
Risk-adapted donor lymphocyte infusion based on chimerism and donor source in pediatric leukemia
P. Rujkijyanont et al.
BLOOD CANCER JOURNAL (2013)
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantation
Christoph Schmid et al.
BLOOD (2012)
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
Eva Rettinger et al.
BLOOD (2011)
Modified donor lymphocyte infusion (DLI) for the prophylaxis of leukemia relapse after hematopoietic stem cell transplantation in patients with advanced leukemia - Feasibility and safety study
Xiao-Jun Huang et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2008)
Biologic and molecular effects of granulocyte colony-stimulating factor in healthy individuals: recent findings and current challenges
Paolo Anderlini et al.
BLOOD (2008)
Donor lymphocyte infusion in the treatment of first Hematological relapse after allogeneic stem-cell transplantation in adults with acute myeloid leukemia:: A retrospective risk factors analysis and comparison with other strategies by the EBMT acute leukemia working party
Christoph Schmid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Donor lymphocyte infusions can result in sustained remissions in patients with residual or relapsed lymphoid malignancy following allogeneic haemopoietic stem cell transplantation
NH Russell et al.
BONE MARROW TRANSPLANTATION (2005)
The impact of granulocyte colony stimulating factor at content of donor lymphocytes collected for cellular immunotherapy
M Arat et al.
TRANSFUSION AND APHERESIS SCIENCE (2004)
Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: Possible role for pre-emptive immunotherapy?
P Bader et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Share Paper
